Nalaganje...
Deubiquitinating enzyme inhibitor alleviates cyclin A1‐mediated proteasome inhibitor tolerance in mixed‐lineage leukemia
Drug resistance is a significant obstacle to effective cancer treatment. Drug resistance develops from initially reversible drug‐tolerant cancer cells, which offer therapeutic opportunities to impede cancer relapse. The mechanisms of resistance to proteasome inhibitor (PI) therapy have been investig...
Shranjeno v:
| izdano v: | Cancer Sci |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2021
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8177811/ https://ncbi.nlm.nih.gov/pubmed/33738896 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14892 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|